Crossmark

Pro-resolving lipid mediators are leads for resolution physiology

Crossref DOI link: https://doi.org/10.1038/nature13479

Published: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Serhan, Charles N.
License Information

Text and Data Mining valid from 2014-06-01
More Information

Article History

Received: 18 December 2013

Accepted: 24 March 2014

First Online: 4 June 2014

Competing interests

: C.N.S. is an inventor of patents (resolvins) assigned to BWH and licensed to Resolvyx Pharmaceuticals. C.N.S. is a scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. The interests of C.N.S. were reviewed and are managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies.